StatPearls, LLC

  • Adrenal Gland Neoplasms
  • Myelolipoma

Adrenal Myelolipoma

Adrenal myelolipomas represent benign adrenal neoplasms primarily consisting of mature adipose tissue intertwined with myeloid tissue. They constitute a noteworthy portion, ranging from 6% to 16%, of adrenal incidentalomas, emerging as the second most frequent etiology following adrenal adenomas. These lesions can exhibit functional or nonfunctional characteristics, adding a layer of complexity to their clinical evaluation and management. This continuing education activity is designed to provide a comprehensive review of the assessment and treatment of adrenal myelolipomas. Additionally, it emphasizes the crucial role of the interprofessional healthcare team in recognizing and effectively managing patients with adrenal myelolipomas. By enhancing our collective understanding of these lesions and promoting interdisciplinary collaboration, we can optimize patient care, refine diagnostic strategies, and tailor treatment plans to individual patient needs.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 7 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left